Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Intrathecal Dexmedetomidine × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Urinary Bladder Neoplasms 2 Colonic Neoplasms 2 Breakthrough Cancer Pain 2 Agnosia 2 Rectal Neoplasms 1 Postoperative Cognitive Complications 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Pain, Postoperative 1 Pain 1 Neoplasms 1 Intrathecal Dexmedetomidine 1 Ileus 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1

Interventions

Fentanyl 1 Dexmedetomidine 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02861716 2018-04-10

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 2 Unknown

Intrathecal Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡